Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328640 · ClinicalTrials.gov registry record · Phase 4
Quality Improvement in Stroke Prevention (QUISP)
A Phase 4 study of Ischemic Stroke, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,500
- Enrollment target
- 1
- Study location
NCT00328640: Completed Phase 4 study of Ischemic Stroke, sponsored by University of California, San Francisco.
NCT00328640 is a Phase 4 study of Ischemic Stroke that has completed, run by University of California, San Francisco. The registered enrollment target is 1,500 participants, roughly in line with the 1,441-participant average among 66 other Ischemic Stroke trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00328640, a Phase 4 study of Ischemic Stroke, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Is a secondary prevention intervention, focused on implementation of standardized pre-printed discharge orders for hospitalists, effective at increasing utilization of the following evidence-based treatments 6 months after discharge for ischemic stroke: 1. Treatment with statins, 2. Control of hypertension, and 3. Anticoagulation in patients with atrial fibrillation.
Conditions Studied
Interventions
- DRUG Optimal treatment
Study Locations (1)
California
- Kaiser-Permanente Division of Research - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00328640 record still lists
NCT00328640 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,441-participant average among 66 other Ischemic Stroke trials with a reported enrollment target.
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Optimal treatment is the first listed.
NCT00328640 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00328640 about?
NCT00328640 is a clinical study titled "Quality Improvement in Stroke Prevention (QUISP)". Is a secondary prevention intervention, focused on implementation of standardized pre-printed discharge orders for hospitalists, effective at increasing utilization of the following evidence-based treatments 6 months after discharge for ischemic stroke: 1. Treatment with statins, 2. Control of hype...
What is the current status of trial NCT00328640?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,500 participants. The study started on 2005-12. Estimated completion is 2007-03.
What conditions does trial NCT00328640 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT00328640?
The interventions under investigation include: Optimal treatment (DRUG).
Who is sponsoring clinical trial NCT00328640?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00328640 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00328640's enrollment target sits among peer trials
1,500 8th of 66 higher than 58 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assess the Penumbra System in the Treatment of Acute Stroke
COMPLETED · Phase 4
-
Patent Foramen Ovale in Cryptogenic Stroke Study
COMPLETED · Phase 4
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia